Differentiation, differentiation/gene therapy and cancer
- 31 December 1997
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 73 (1), 51-65
- https://doi.org/10.1016/s0163-7258(96)00120-9
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised studyEuropean Journal Of Cancer, 1994
- Induction of c-jun independent of PKC, pertussis toxin-sensitive G protein, and polyamines in quiescent SV40-transformed 3T3 T cellsExperimental Cell Research, 1992
- Insulin‐induced mitogenesis associated with transformation by the SV40 large T antigenJournal of Cellular Physiology, 1991
- Three distinct effects of SV40 T‐antigen gene transfection on cellular differentiationJournal of Cellular Physiology, 1990
- Nonterminally differentiated cells express decreased growth factor responsivenessJournal of Cellular Physiology, 1989
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- Response of Preleukemic Syndromes to Continuous Infusion of Low-Dose CytarabineNew England Journal of Medicine, 1983
- Differential mitogenic effects of methyl isobutyl xanthine and a tumor growth factor on G1-arrested 3T3 T proadipocytes at the predifferentiation GD state and the growth-factor deficiency GS stateExperimental Cell Research, 1983
- Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.The Journal of cell biology, 1982